Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000415719 | SCV000543706 | likely benign | Aortic aneurysm, familial thoracic 4 | 2024-10-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000415719 | SCV000894981 | uncertain significance | Aortic aneurysm, familial thoracic 4 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000772071 | SCV000905100 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Department of Vascular Biology, |
RCV001374827 | SCV001439576 | uncertain significance | Isolated thoracic aortic aneurysm | 2018-09-01 | criteria provided, single submitter | research | |
Gene |
RCV001555668 | SCV001777120 | likely benign | not provided | 2018-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001555668 | SCV005051352 | likely benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | MYH11: BS1 |
Ambry Genetics | RCV004955472 | SCV005454432 | likely benign | Inborn genetic diseases | 2024-08-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ambry Genetics | RCV000772071 | SCV005455971 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-08-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Knight Diagnostic Laboratories, |
RCV000415719 | SCV000493768 | uncertain significance | Aortic aneurysm, familial thoracic 4 | 2016-03-30 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004751513 | SCV005365381 | likely benign | MYH11-related disorder | 2024-08-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |